The effect of zolpidem-CR on the suicide item of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia and suicidal ideation: Lessons learned

William V. McCall, Kayla Mercado, Tess N. Dzurny, Laryssa L. McCloud, Andrew D. Krystal, Ruth M. Benca, Peter B. Rosenquist, Stephen W. Looney

Research output: Contribution to journalArticlepeer-review

Abstract

The REST-IT study found the addition of zolpidem-controlled release (CR) provided a significant reduction in observer-rated measurement of suicidal ideation (the Columbia Suicide Severity Rating Scale) in 103 depressed outpatients with insomnia and suicidal ideation, but without significant change in a self-report measure of suicidal ideation (the Scale for Suicide Ideation). This secondary analysis of the REST-IT data examined the suicide item of another observer-rated scale, the Hamilton Rating Scale for Depression (HRSD), further clarifying the impact of insomnia-focused treatment on suicidal ideation. This analysis established a significant advantage for zolpidem-CR compared with placebo on the HRSD suicide item.

Original languageEnglish (US)
Article number115576
JournalPsychiatry Research
Volume330
DOIs
StatePublished - Dec 2023

Keywords

  • Hypnotic
  • Observer-rated
  • Self-report

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'The effect of zolpidem-CR on the suicide item of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia and suicidal ideation: Lessons learned'. Together they form a unique fingerprint.

Cite this